An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point

Circulation. 1992 Aug;86(2):683-7. doi: 10.1161/01.cir.86.2.683.

Authors

E Braunwald¹, C P Cannon, C H McCabe

Affiliation

¹ Department of Medicine, Harvard Medical School, Boston, MA.

PMID: 1638732
DOI: 10.1161/01.cir.86.2.683

No abstract available

MeSH terms

Cerebrovascular Disorders / epidemiology
Clinical Trials as Topic
Fibrinolytic Agents / therapeutic use*
Heart Failure / epidemiology
Humans
Myocardial Infarction / drug therapy*
Myocardial Infarction / mortality
Recurrence
Shock, Cardiogenic / epidemiology
Thrombolytic Therapy*
Treatment Outcome

Substances

Fibrinolytic Agents